METHOD FOR TREATING ACUTE PURULENT-DESTRUCTIVE PULMONARY DISEASES Russian patent published in 2006 - IPC A61K38/21 A61P11/00 A61M1/38 

FIELD: medicine, resuscitation, thoracic surgery, pulmonology.

SUBSTANCE: the present innovation refers to detoxication methods and could be applied at treating acute purulent-destructive pulmonary diseases. After sanitation of purulent focus it is necessary to introduce perorally Reaferon-EC-Lipint at the dosage of 10000-15000 U/kg. After that, one should sample blood followed by extracorporal treatment of leukocytes with immunophan. Then treated leukocytes should be intravenously injected for a patient by drops. Starting since the next day it is necessary to introduce Reaferon-EC-Lipint again perorally at the dosage of 10000-15000 U/kg once daily. Therapy course should last for 5 d. The innovation enables to increase efficiency in treating acute purulent-destructive pulmonary diseases and, also, prevent septic complications in patients at such a pathology due to correcting immune state in patients by normalizing cellular phagocytic link and decreasing the circulating immune complexes.

EFFECT: higher efficiency of therapy.

3 ex, 1 tbl